Gaobo Medical Group

Gaobo Medical Group has always adhered to the concept of "patient needs first", with the mission and vision of pursuing excellent diagnosis and treatment, breaking through innovative technology, and creating life possibilities, committed to building a clinical-driven innovative medical technology platform.

The Group was established in 2017, focusing on clinical diagnosis and treatment, clinical research, reference laboratories, and informatization. The Group, together with a group of outstanding medical experts with rich clinical experience and scientific research capabilities, jointly creates a unique "academic-led clinical research organization" (ARO-Academic Research Organization). The organizational strategy is to build an innovative medical ecosystem of "clinical discovery - basic research - industrial transformation - clinical application", improving the efficiency and quality of the biopharmaceutical industry.

Research hospitals are an important carrier of the ARO model, and Gaobo Group is an explorer of the domestic research hospital model. Currently, it operates 8 hospitals in Beijing, Shanghai, and Guangzhou, with nearly 1,500 open beds in total. It focuses on active specialized fields such as solid tumors, hematological diseases, and brain science. Under its umbrella, it has established professional service segments including Phase I clinical trial wards, central laboratories, early clinical research centers, clinical pharmacology, medical and statistics.

With the medical mission of conquering difficult and severe diseases, it brings more treatment options and hope to patients with difficult and severe diseases. With the scientific research mission of promoting medical innovation, Gaobo has served hundreds of innovative drug companies in hundreds of clinical trials for innovative drugs. Medicine progresses because of encouraging innovation, and innovation shines because of embracing medicine.